Chemo-radiotherapy in non-small cell lung cancer: The role of gemcitabine

L. Trodella, R. M. D'Angelillo, S. Ramella, F. Cellini, M. Ciresa, A. Cesario, P. Granone

Research output: Contribution to journalArticlepeer-review


Gemcitabine (2′-2′-difluorodeoxycytidine) is a well-known cytotoxic drug and a potent radio-enhancer. We herein report the in vitro evidence of its activity, and the clinical experiences when this drug is administered concurrently with radiation. The phase I-II trials are analyzed, focusing on the recent ability to deliver irradiation with low incidence of side effects.

Original languageEnglish
JournalAnnals of Oncology
Issue numberSUPPL. 5
Publication statusPublished - May 2006

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Chemo-radiotherapy in non-small cell lung cancer: The role of gemcitabine'. Together they form a unique fingerprint.

Cite this